Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

US Patent 11400097 · Granted Aug 2, 2022

Estimated economic value: $1,628,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanised anti-n-truncated amyloid β monoclonal antibody2025
Humanised anti-IL17BR antibody2025
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2024
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2024
Resealable bag enclosure2023
Anti-transglutaminase 2 antibodies2023
Method of feeding web and reclosures to a form fill seal machine2022
Anti-transglutaminase 2 antibodies2021
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2020
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2020
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2019
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-2019